Who Owns Life?
| PUBLISHER | Prometheus Books (04/01/2002) |
| PRODUCT TYPE | Hardcover (Hardcover) |
Description
With the mapping of the human genome and the development of cloning and other genetic engineering techniques, scientists have embarked upon a whole new era of biomedical research and with it a maze of complex ethical and legal questions. Do isolated gene sequences constitute 'inventions' that warrant patent protection? What about cloned organisms, or new life forms engineered from pre-existing tissue? Do scientists have the right to claim individual patents on and make profits from the elements of life? How does the profit motive affect our attitudes toward the value of life? Will patent protection foster or hinder scientific cooperation and research into diseases? These are a few of the vexing questions that must be faced in the coming decades as biotechnology advances into uncharted ethical territory. This excellent collection of articles by scientists, ethicists, and legal experts analyzes the convergence of biotechnology and intellectual property legislation, which has given rise to these new moral dilemmas. It will serve as a valuable reference work to give educated lay readers a starting point to make their own judgments about matters we will all face in the near future.
Show More
Product Format
Product Details
ISBN-13:
9781573929868
ISBN-10:
1573929867
Binding:
Hardback or Cased Book (Sewn)
Content Language:
English
More Product Details
Page Count:
300
Carton Quantity:
20
Product Dimensions:
6.18 x 0.82 x 9.26 inches
Weight:
1.19 pound(s)
Feature Codes:
Index,
Dust Cover,
Price on Product,
Table of Contents,
Glossary,
Illustrated
Country of Origin:
CA
Subject Information
BISAC Categories
Science | Philosophy & Social Aspects
Science | Life Sciences - Genetics & Genomics
Science | Biotechnology
Dewey Decimal:
174.25
Library of Congress Control Number:
2002070509
Descriptions, Reviews, Etc.
annotation
This excellent collection of articles by scientists, ethicists, and legal experts analyzes the convergence of biotechnology and intellectual property legislation, which has give rise to new moral dilemmas. It serves as a valuable reference so readers can make their own judgments.
Show More
publisher marketing
With the mapping of the human genome and the development of cloning and other genetic engineering techniques, scientists have embarked upon a whole new era of biomedical research and with it a maze of complex ethical and legal questions. Do isolated gene sequences constitute 'inventions' that warrant patent protection? What about cloned organisms, or new life forms engineered from pre-existing tissue? Do scientists have the right to claim individual patents on and make profits from the elements of life? How does the profit motive affect our attitudes toward the value of life? Will patent protection foster or hinder scientific cooperation and research into diseases? These are a few of the vexing questions that must be faced in the coming decades as biotechnology advances into uncharted ethical territory. This excellent collection of articles by scientists, ethicists, and legal experts analyzes the convergence of biotechnology and intellectual property legislation, which has given rise to these new moral dilemmas. It will serve as a valuable reference work to give educated lay readers a starting point to make their own judgments about matters we will all face in the near future.
Show More
Editor:
Caplan, Arthur L.
Arthur L. Caplan is Director of the Division of Medical Ethics in the Department of Population Health at New York University's Langone Medical Center.
Show More
List Price $26.99
Your Price
$26.72